SEARCH

SEARCH BY CITATION

References

  • 1
    Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens–Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131: 539543.
  • 2
    French LE, Prins C. Erythema multiforme, Stevens–Johnson syndrome and toxic epidermal necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology, 2nd edn, Vol. 1. St Louis, MO: Mosby Elsevier, 2008: 287300.
  • 3
    Wetter DA, Davis MD. Recurrent erythema multiforme: clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000–2007. J Am Acad Dermatol 2010; 62: 4553.
  • 4
    Bastuji-Garin S, Rzany B, Stern RS, et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens–Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 9296.
  • 5
    Auquier-Dunant A, Mockenhaupt M, Naldi L, et al. Severe cutaneous adverse reactions. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens–Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138: 10191024.
  • 6
    Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983; 8: 763775.
  • 7
    Weston WL. Herpes-associated erythema multiforme. J Invest Dermatol 2005; 124: xvxvi.
  • 8
    Roujeau J-C. Erythema multiforme. In: Wolff K, Goldsmith LA, Katz SI, et al. , eds. Fitzpatrick’s Dermatology in General Medicine, 7th edn. [Internet.] New York, NY: McGraw-Hill, 2008. Available at: http://www.accessmedicine.com/content.aspx?aID=2970488 (Accessed April 3 2011).
  • 9
    Schalock PC, Dinulos JG, Pace N, et al. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Pediatr Dermatol 2006; 23: 546555.
  • 10
    Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993; 128: 542545.
  • 11
    Huff JC, Weston WL. Recurrent erythema multiforme. Medicine (Baltimore) 1989; 68: 133140.
  • 12
    Lewis MA, Lamey PJ, Forsyth A, Gall J. Recurrent erythema multiforme: a possible role of foodstuffs. Br Dent J 1989; 166: 371373.
  • 13
    Dumas V, Thieulent N, Souillet AL, et al. Recurrent erythema multiforme and chronic hepatitis C: efficacy of interferon alpha. Br J Dermatol 2000; 142: 12481249.
  • 14
    Brice SL, Leahy MA, Ong L, et al. Examination of non-involved skin, previously involved skin, and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes-associated erythema multiforme. J Cutan Pathol 1994; 21: 408412.
  • 15
    Ng PP, Sun YJ, Tan HH, Tan SH. Detection of herpes simplex virus genomic DNA in various subsets of erythema multiforme by polymerase chain reaction. Dermatology 2003; 207: 349353.
  • 16
    Drago F, Parodi A, Rebora A. Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 1995; 33: 366369.
  • 17
    Chen CW, Tsai TF, Chen YF, Hung CM. Persistent erythema multiforme treated with thalidomide. Am J Clin Dermatol 2008; 9: 123127.
  • 18
    Wanner M, Pol-Rodriguez M, Hinds G, et al. Persistent erythema multiforme and CMV infection. J Drugs Dermatol 2007; 6: 333336.
  • 19
    Khalil I, Lepage V, Douay C, et al. HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme. J Invest Dermatol 1991; 97: 697700.
  • 20
    Weedon D. Weedon’s Skin Pathology, 3rd edn. Edinburgh: Churchill Livingstone/Elsevier, 2010; 50–53, 202–207, 536538.
  • 21
    Ono F, Sharma BK, Smith CC, et al. CD34+ cells in the peripheral blood transport herpes simplex virus DNA fragments to the skin of patients with erythema multiforme (HAEM). J Invest Dermatol 2005; 124: 12151224.
  • 22
    Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol Online J 2003; 9: 1.
  • 23
    Ahdout J, Haley JC, Chiu MW. Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis. J Am Acad Dermatol 2010; 62: 874879.
  • 24
    Huff JC. Erythema multiforme. Dermatol Clin 1985; 3: 141152.
  • 25
    Orfanos CE, Schaumburg-Lever G, Lever WF. Dermal and epidermal types of erythema multiforme: a histopathologic study of 24 cases. Arch Dermatol 1974; 109: 682688.
  • 26
    Ohtani T, Deguchi M, Aiba S. Erythema multiforme-like lesions associated with lesional infiltration of tumor cells occurring with adult T cell lymphoma/leukemia. Int J Dermatol 2008; 47: 390392.
  • 27
    Davidson DM, Jegasothy BV. Atypical erythema multiforme: a marker of malignancy? Report of a case occurring with renal cell carcinoma. Cutis 1980; 26: 276278.
  • 28
    Tzovaras V, Liberopoulos EN, Zioga A, et al. Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinoma. Oncology 2007; 73: 127129.
  • 29
    Wetter DA, Camilleri MJ. Clinical, etiologic, and histopathologic features of Stevens–Johnson syndrome during an 8-year period at Mayo Clinic. Mayo Clin Proc 2010; 85: 131138.
  • 30
    Shear NH, Knowles SR, Shapiro L. Cutaneous reactions to drugs. In: Wolff K, Goldsmith LA, Katz SI, et al. , eds. Fitzpatrick’s Dermatology in General Medicine, 7th edn. [Internet.] New York, NY: McGraw-Hill, 2008. Available at: http://www.accessmedicine.com/content.aspx?aID=2967865 (Accessed April 3 2011).
  • 31
    Stanley JR. Bullous pemphigoid. In: Wolff K, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick’s Dermatology in General Medicine, 7th edn. [Internet.] New York, NY: McGraw-Hill, 2008. Available at: http://www.accessmedicine.com/content.aspx?aID=2950538 (Accessed April 3 2011).
  • 32
    Anhalt GJ, Nousari CH. Paraneoplastic pemphigus. In: Wolff K, Goldsmith LA, Katz SI, et al. , eds. Fitzpatrick’s Dermatology in General Medicine, 7th edn. [Internet.] New York, NY: McGraw-Hill, 2008. Available at: http://www.accessmedicine.com/content.aspx?aID=2970867 (Accessed April 3 2011).
  • 33
    Cohen PR, Hoenigsmann H, Kurzrock R. Acute febrile neutrophilic dermatosis (Sweet syndrome). In: Wolff K, Goldsmith LA, Katz SI, et al. , eds. Fitzpatrick’s Dermatology in General Medicine, 7th edn. [Internet.] New York, NY: McGraw-Hill, 2008. Available at: http://www.accessmedicine.com/content.aspx?aID=2952280 (Accessed April 3 2011).
  • 34
    Lee A, Batra P, Furer V, et al. Rowell syndrome (systemic lupus erythematosus + erythema multiforme). Dermatol Online J 2009; 15: 1.
  • 35
    Hughey LC. Approach to the hospitalized patient with targetoid lesions. Dermatol Ther 2011; 24: 196206.
  • 36
    Piette WW. Primary systemic vasculitis. In: Sontheimer RD, Provost TT, eds. Cutaneous Manifestations of Rheumatic Diseases, 2nd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2004; 159196.
  • 37
    Tatnall FM, Schofield JK, Leigh IM. A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme. Br J Dermatol 1995; 132: 267270.
  • 38
    Fawcett HA, Wansbrough-Jones MH, Clark AE, Leigh IM. Prophylactic topical acyclovir for frequent recurrent herpes simplex infection with and without erythema multiforme. Br Med J (Clin Res Ed) 1983; 287: 798799.
  • 39
    Davis MD, Rogers RS III, Pittelkow MR. Recurrent erythema multiforme/Stevens–Johnson syndrome: response to mycophenolate mofetil. Arch Dermatol 2002; 138: 15471550.